Christopher Kuebler - Director, Nektar Therapeutics
As of October 1, 2018
Christopher Kuebler Net Worth
- Net worth is estimated to be at least $19.94M
- Owns at least 40,500 units of Nektar Therapeutics stock
- Sold an estimated value of $6.99M in the last 15 years at Nektar Therapeutics
Christopher Kuebler Trading
- Largest purchase of shares was 30,000 units , worth over $427.8K on January 4, 2018
- Largest sale of shares was 40,000 units , worth over $3.9M on March 8, 2018
- In total has made about 29 transactions over 15 years
- Usually trades in September, with the busiest year in 2015, 2018 and 2017
CHRISTOPHER KUEBLER
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
Christopher Kuebler Mailing Address
- Mailing address is 210 Carnegie Center Princeton NJ 08540 NJ
Nektar Therapeutics Insider Trading
- The most recent transaction was 21,673 units sold on May 17, 2022 by Jonathan Zalevsky worth over $85.61K
- In the last 19 years, insiders at Nektar Therapeutics sold an estimated value of $294.28M and bought an estimated value of $84.98M
- The most active traders are Gil Labrucherie, SVP, Howard Robin, President & CEO, and Robert Chess, Director
- Insider trading is most common in September, with the busiest year in 2016 and 2017
NEKTAR THERAPEUTICS Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |